GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PhotoCure ASA (OTCPK:PHCUF) » Definitions » Cyclically Adjusted Price-to-FCF

PhotoCure ASA (PhotoCure ASA) Cyclically Adjusted Price-to-FCF : (As of Jun. 24, 2024)


View and export this data going back to . Start your Free Trial

What is PhotoCure ASA Cyclically Adjusted Price-to-FCF?

Shiller PE for Stocks: The True Measure of Stock Valuation


PhotoCure ASA Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for PhotoCure ASA's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PhotoCure ASA Cyclically Adjusted Price-to-FCF Chart

PhotoCure ASA Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

PhotoCure ASA Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of PhotoCure ASA's Cyclically Adjusted Price-to-FCF

For the Drug Manufacturers - Specialty & Generic subindustry, PhotoCure ASA's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PhotoCure ASA's Cyclically Adjusted Price-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, PhotoCure ASA's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where PhotoCure ASA's Cyclically Adjusted Price-to-FCF falls into.



PhotoCure ASA Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

PhotoCure ASA's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, PhotoCure ASA's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2024 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.008/132.6000*132.6000
=0.008

Current CPI (Mar. 2024) = 132.6000.

PhotoCure ASA Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201406 -0.079 97.500 -0.107
201409 0.186 98.500 0.250
201412 -0.023 98.600 -0.031
201503 -0.102 99.200 -0.136
201506 -0.027 100.100 -0.036
201509 -0.046 100.600 -0.061
201512 -0.031 100.900 -0.041
201603 -0.076 102.500 -0.098
201606 -0.093 103.800 -0.119
201609 -0.069 104.200 -0.088
201612 0.219 104.400 0.278
201703 -0.080 105.000 -0.101
201706 -0.105 105.800 -0.132
201709 -0.086 105.900 -0.108
201712 0.033 106.100 0.041
201803 -0.113 107.300 -0.140
201806 -0.073 108.500 -0.089
201809 -0.030 109.500 -0.036
201812 0.056 109.800 0.068
201903 -0.086 110.400 -0.103
201906 -0.023 110.600 -0.028
201909 0.049 111.100 0.058
201912 0.153 111.300 0.182
202003 0.009 111.200 0.011
202006 0.050 112.100 0.059
202009 -0.717 112.900 -0.842
202012 0.764 112.900 0.897
202103 -0.013 114.600 -0.015
202106 0.064 115.300 0.074
202109 0.011 117.500 0.012
202112 0.027 118.900 0.030
202203 -0.094 119.800 -0.104
202206 -0.009 122.600 -0.010
202209 0.075 125.600 0.079
202212 -0.006 125.900 -0.006
202303 -0.038 127.600 -0.039
202306 0.096 130.400 0.098
202309 0.010 129.800 0.010
202312 0.057 131.900 0.057
202403 0.008 132.600 0.008

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


PhotoCure ASA  (OTCPK:PHCUF) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


PhotoCure ASA Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of PhotoCure ASA's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


PhotoCure ASA (PhotoCure ASA) Business Description

Industry
Traded in Other Exchanges
Address
Hoffsveien 4, Oslo, NOR, 0275
PhotoCure ASA is a Norway-based business group associated with the research, development, production, distribution, marketing, and sales of pharmaceutical products specialty pharmaceutical companies. Its technology platform is focused on the field of photodynamic diagnosis and treatment of cancer. It has two operating segments of the group the Commercial franchise and the Development portfolio. It generates prime revenue from the Commercial franchise segment, which includes Hexvix and Cysview products. Its geographical segments are Nordic countries, Germany, France, Austria, the United Kingdom, Netherlands, Other European countries, and the United States.